Akbank T.A.S. (ADR) Earnings Calls
| Release date | Oct 23, 2025 |
| EPS estimate | $0.114 |
| EPS actual | $0.130 |
| EPS Surprise | 13.94% |
| Revenue estimate | 1.331B |
| Revenue actual | 1.478B |
| Revenue Surprise | 11.06% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.154 |
| EPS actual | $0.110 |
| EPS Surprise | -28.71% |
| Revenue estimate | 1.933B |
| Revenue actual | 4.807B |
| Revenue Surprise | 148.72% |
| Release date | Apr 25, 2025 |
| EPS estimate | $0.0965 |
| EPS actual | $0.150 |
| EPS Surprise | 55.44% |
| Revenue estimate | 1.363B |
| Revenue actual | 4.752B |
| Revenue Surprise | 248.71% |
| Release date | Jan 30, 2025 |
| EPS estimate | $0.104 |
| EPS actual | $0.0990 |
| EPS Surprise | -4.84% |
| Revenue estimate | 1.216B |
| Revenue actual | 1.227B |
| Revenue Surprise | 0.93% |
Last 4 Quarters for Akbank T.A.S. (ADR)
Below you can see how AKBTY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 30, 2025 |
| Price on release | $3.62 |
| EPS estimate | $0.104 |
| EPS actual | $0.0990 |
| EPS surprise | -4.84% |
| Date | Price |
|---|---|
| Jan 24, 2025 | $3.79 |
| Jan 27, 2025 | $3.60 |
| Jan 28, 2025 | $3.75 |
| Jan 29, 2025 | $3.84 |
| Jan 30, 2025 | $3.62 |
| Jan 31, 2025 | $3.52 |
| Feb 03, 2025 | $3.55 |
| Feb 04, 2025 | $3.62 |
| Feb 05, 2025 | $3.43 |
| 4 days before | -4.49% |
| 4 days after | -5.25% |
| On release day | -2.76% |
| Change in period | -9.50% |
| Release date | Apr 25, 2025 |
| Price on release | $2.55 |
| EPS estimate | $0.0965 |
| EPS actual | $0.150 |
| EPS surprise | 55.44% |
| Date | Price |
|---|---|
| Apr 21, 2025 | $2.48 |
| Apr 22, 2025 | $2.63 |
| Apr 23, 2025 | $2.55 |
| Apr 24, 2025 | $2.72 |
| Apr 25, 2025 | $2.55 |
| Apr 28, 2025 | $2.60 |
| Apr 29, 2025 | $2.50 |
| Apr 30, 2025 | $2.64 |
| May 01, 2025 | $2.56 |
| 4 days before | 2.82% |
| 4 days after | 0.392% |
| On release day | 0% |
| Change in period | 3.23% |
| Release date | Jul 29, 2025 |
| Price on release | $3.28 |
| EPS estimate | $0.154 |
| EPS actual | $0.110 |
| EPS surprise | -28.71% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $3.25 |
| Jul 24, 2025 | $3.32 |
| Jul 25, 2025 | $3.20 |
| Jul 28, 2025 | $3.11 |
| Jul 29, 2025 | $3.28 |
| Jul 30, 2025 | $3.31 |
| Jul 31, 2025 | $3.40 |
| Aug 01, 2025 | $3.25 |
| Aug 04, 2025 | $3.36 |
| 4 days before | 0.92% |
| 4 days after | 2.44% |
| On release day | 0.91% |
| Change in period | 3.38% |
| Release date | Oct 23, 2025 |
| Price on release | $2.77 |
| EPS estimate | $0.114 |
| EPS actual | $0.130 |
| EPS surprise | 13.94% |
| Date | Price |
|---|---|
| Oct 17, 2025 | $2.52 |
| Oct 20, 2025 | $2.80 |
| Oct 21, 2025 | $2.71 |
| Oct 22, 2025 | $2.65 |
| Oct 23, 2025 | $2.77 |
| Oct 24, 2025 | $2.85 |
| Oct 27, 2025 | $2.88 |
| Oct 28, 2025 | $2.68 |
| Oct 29, 2025 | $2.63 |
| 4 days before | 9.92% |
| 4 days after | -5.05% |
| On release day | 2.89% |
| Change in period | 4.37% |
Akbank T.A.S. (ADR) Earnings Call Transcript Summary of Q3 2025
Key investor takeaways: 1) Strong top-line and earnings momentum: 9M net income TRY 38.9bn (ROE 20.4%), 9M revenues TRY 156.0bn (+48% yoy) driven by a resurgent NII in 3Q and very strong fees. 2) Loan growth ahead of plan: TL loans up 28% YTD (13% q/q), on track to beat the prior full‑year TL growth target (>30%); FX loans up modestly with a mid-single-digit full-year target and upside from pipelines. 3) Margin recovery but guidance risk: Swap‑adjusted NII rebounded sharply in 3Q (swap‑adjusted NII +48% q/q; NIM expanded ~73bps q/q). Management warns the pace and magnitude of future policy rate cuts will determine NIM trajectory; current macro implies NIM/ROE guidance risk for year‑end. 4) Deposit and funding strength: Market share gains in TL demand deposits (private banks) and lower-cost deposit share improving; TL LDR remains low — providing room to optimize funding costs. 5) Fees and efficiency: Net fees +67% yoy; fee/OpEx >100% (104% YTD) as fee growth outpaced OpEx (+35% YTD). 6) Asset quality and provisioning: NPL ratio stable at 3.5%; restructured loans 3.2% of book (up 0.6pp q/q, largely due to BRSA restructuring scheme), Stage 2+3 ~9% of loans. Total provisions ~TRY 68bn YTD; cumulative net cost of credit ~230bps (may slightly exceed prior 150–200bp guidance). 7) Capital and sensitivity: Total capital 17.2%, Tier‑1 13.6%, CET1 12.4% (no forbearances). Sensitivities limited (10% TL depreciation ≈ -29bps to capital ratios; 100bp TL rate rise ≈ -9bps). 8) ESG: Progress on sustainability targets (74% of sustainable finance target achieved), maintained MSCI AA. Bottom line: the bank is delivering quality growth with strong fee momentum, solid capital and disciplined risk management; near‑term upside to margins depends materially on the speed and size of policy easing, so investors should watch NIM, cost of risk developments and any regulatory moves on interchange/fees.
Sign In
Buy AKBTY